Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Core Laboratories (CLB) Net Margin (2022 - 2025)

Core Laboratories' Net Margin history spans 4 years, with the latest figure at 4.71% for Q4 2025.

  • For Q4 2025, Net Margin fell 155.0% year-over-year to 4.71%; the TTM value through Dec 2025 reached 6.04%, down 20.0%, while the annual FY2025 figure was 6.04%, 22.0% down from the prior year.
  • Net Margin reached 4.71% in Q4 2025 per CLB's latest filing, down from 10.8% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 17.93% in Q2 2023 to a low of 6.73% in Q4 2023.
  • Average Net Margin over 4 years is 5.72%, with a median of 6.04% recorded in 2022.
  • Peak YoY movement for Net Margin: plummeted -1146bps in 2023, then surged 1299bps in 2024.
  • A 4-year view of Net Margin shows it stood at 4.73% in 2022, then plummeted by -242bps to 6.73% in 2023, then skyrocketed by 193bps to 6.26% in 2024, then decreased by -25bps to 4.71% in 2025.
  • Per Business Quant, the three most recent readings for CLB's Net Margin are 4.71% (Q4 2025), 10.8% (Q3 2025), and 8.21% (Q2 2025).